Jain Global’s Novartis NVS Stock Holding History

Jain Global’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743K	Buy	+4,742	New	+$711K	﹤0.01%	1077
2025 Q3	–	Sell	-5,300	Closed	-$641K	–	1353
2025 Q2	$641K	Buy	+5,300	New	+$597K	0.01%	737

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jain Global's NVS Position: Q2 2026 in Review

Jain Global opened a new position in Novartis (NVS) in Q2 2026: 4,742 shares worth $743K. The stake represents ﹤0.01% of the portfolio and ranks #1077 among its holdings. This is a return to the name: Jain Global previously reported a position in NVS as recently as Q2 2025.

Jain Global first reported a position in NVS in Q2 2025 and has held it in 2 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Jain Global held 4,742 shares of Novartis worth $743K as of Q2 2026.
Novartis was a new Jain Global position in Q2 2026.
Novartis made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1077 holding.
Jain Global first reported a position in Novartis in Q2 2025 and has held it in 2 quarters since.
1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.